Lab Automation in Bioanalysis Market Share

Statistics for the 2023 & 2024 Lab Automation in Bioanalysis market share, created by Mordor Intelligence™ Industry Reports. Lab Automation in Bioanalysis share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Lab Automation in Bioanalysis Industry

The lab automation in bioanalysis market is consolidated. Major players have the maximum market share. Also, the players in the lab automation in bioanalysis market are increasingly competing against each other based on factors such as product innovations and technological advances.

  • May 2022 - Thermo Fisher Scientific introduced the Automated Indiko Clinical Chemistry analyzer, which produces results quickly with sample-oriented testing. It can operate with low sample volumes and uses small amounts of water which enables running the laboratory more cost-efficiently.
  • February 2021 - Beckman Coulter announced the launch of the DxH 560 AL, a tabletop hematology analyzer designed to reduce the time and resource constraints faced by small- to mid-sized laboratories. With its auto-loading functionality, closed tube aspiration, and walk away capabilities, users can continually add up to 50 samples, provide safety against blood-borne pathogens and spend less time on manual instrument tasks.

Lab Automation in Bioanalysis Market Leaders

  1. Thermo Fisher Scientific

  2. Agilent Technologies

  3. Hamilton Company

  4. Siemens Healthineers AG

  5. Becton Dickinson & Co.

*Disclaimer: Major Players sorted in no particular order

Thermo Fisher Scientific, Beckman Coulter (Danaher Corporation), Hudson Robotics, Becton Dickinson, Synchron Lab Automation

Lab Automation in Bioanalysis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2024 - 2029)